Aptose Biosciences
APTO
#10583
Rank
ยฃ3.22 M
Marketcap
ยฃ1.26
Share price
0.00%
Change (1 day)
-43.66%
Change (1 year)

Earnings for Aptose Biosciences (APTO)

Earnings in 2025 (TTM): -ยฃ16.16 Million

According to Aptose Biosciences's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ18.66 Million, an increase over its 2023 earnings that were of -ยฃ38.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aptose Biosciences from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ16.16 Million-13.4%
2024 -ยฃ18.66 Million-51.82%
2023 -ยฃ38.73 Million22.9%
2022 -ยฃ31.52 Million-34.91%
2021 -ยฃ48.42 Million17.36%
2020 -ยฃ41.26 Million107.65%
2019 -ยฃ19.87 Million-7.73%
2018 -ยฃ21.54 Million160.68%
2017 -ยฃ8.26 Million-20.27%
2016 -ยฃ10.36 Million28.71%
2015 -ยฃ8.05 Million
2013 -ยฃ4.57 Million
2010 -ยฃ3.89 Million-8.31%
2009 -ยฃ4.24 Million
2006 -ยฃ7.86 Million-156.93%
2005 ยฃ13.8 M-185.16%
2004 -ยฃ16.21 Million458.58%
2003 -ยฃ2.91 Million-63.66%
2002 -ยฃ7.99 Million-8.04%
2001 -ยฃ8.69 Million16.73%
2000 -ยฃ7.44 Million294.99%
1999 -ยฃ1.89 Million-6.51%
1998 -ยฃ2.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ImmunoGen
IMGN
-ยฃ46.44 Million 200.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
-ยฃ49.95 Million 222.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-ยฃ25.17 Million 62.62%๐Ÿ‡บ๐Ÿ‡ธ USA